Hengeler Mueller advises Charles River Laboratories on acquisition of Oncotest
25. November 2015
Charles River Laboratories International Inc. (“Charles River Laboratories”) last week announced the acquisition of Oncotest GmbH. The transaction volume amounts to EUR 34 m plus EUR 2 m payable subject to the further development of the company.
Charles River Laboratories is a full service, early-stage contract research company providing services to pharmaceutical and biotech companies. Oncotest GmbH provides research and validation services for pharmaceutical and biotech companies in the area of preclinical cancer research.
Hengeler Mueller advised Charles River Laboratories on the acquisition. The Hengeler Mueller team included partners Ulrich Blech, Stefan Richter (both M&A, Berlin), Matthias Scheifele (Tax, Frankfurt), Hendrik Bockenheimer (Labour, Frankfurt), Jan D. Bonhage (Public Law, Berlin), counsels Katharina Wodarz (Health Care, Berlin) and Fabian Seip (IP, Berlin) as well as associates Tim Schlösser, David Huthmacher, Alexander Bekier, Mandana Bahrampour, Steven Leunert (all M&A) Ines Oeßelmann, Tilmann Gäde, Maximilian Ohrloff (all Public Law/Health Care) (all Berlin), Robert Rentsch (Labour) and Marc Gossmann (Tax) (both Frankfurt). The seller was advised by Heuking Kühn Lüer Wojtek.